In CRC, in contrast, STK11 mutations are not enriched in KRAS G12C-mutant tumors, while the rate of PIK3CA co-mutations is slightly increased compared to other KRAS mutants [10,31]. The gene discussed is KRAS; the disease is colorectal carcinoma.